Deal▲ Bullish for Dr Lal PathLabs

Dr Lal PathLabs to buy 70% of SN Genelab; reports differ on deal value

4 sources · first seen 19:02 24 Sept · updated 17:52 25 Sept

The brief

Written from 4 reports · check the source before you trade

Dr Lal PathLabs will acquire a **70% stake** in SN Genelab
Reports put the deal value at **₹168 crore** and ₹200 crore
The genomics expansion matters for Dr Lal PathLabs’ diagnostics business and shareholders

the session the news first traded, and since

Stock	Traded	That day	vs Nifty	Volume	Since
LALPATHLAB	Fri, 25 Sept	−0.5%	−0.8%	1.5×	−0.5% · Nifty +0.3%

✗ Classifier read this as positive; LALPATHLAB fell 0.8% against the Nifty on the day it traded.

Pick a tag to see all its stories

4 reports · earliest 19:02